Every day matters for Muk
Why we are asking for your help again
You have already raised more than a million euros for Muk. We are incredibly grateful. We now know that her treatment alone costs €3.5 million. That is far more than we previously knew.

We did not see this coming either
We understand that this amount raises questions. You may feel confused or disappointed, especially if you have already donated. It is difficult for us to take in, too. But your support has not been in vain: it is the foundation that allows us to keep going.
The amount is enormous. Still, we cannot give up on Muk. We are also exploring what we can contribute ourselves and what other financial options are available. With your help, we hope to get as far as we can.
Why is more money needed now?
Only after the FDA approved FAYUVI on 17 September 2026 did we learn how high the treatment price is. Converted into euros, the treatment alone costs €3.5 million. We did not know this price when we started the campaign. That is why we are continuing to raise funds to make treatment accessible for Muk.
Why does this treatment cost so much?
FAYUVI is a specialised, one-time gene therapy for a very rare disease. It follows years of research and is produced in specialised facilities. We do not set the price ourselves and do not have a complete breakdown of it. Our focus is on making this treatment accessible for Muk.
Is there a lower price if we pay for treatment ourselves?
We have asked whether a lower price is available for families paying themselves. Based on the response we received, it is not. We therefore need to plan around the treatment amount that has now been communicated to us for Muk.
When can the first children be treated?
According to the information we currently have, the first patients are expected to be treated around mid-November 2026. This is not a confirmed treatment date for Muk. We want to do everything we can to help her receive treatment as soon as possible and are working on the medical and financial preparation. Her disease does not wait.
Are you also exploring other ways to pay for treatment?
Yes. Alongside fundraising, we are exploring what we can contribute ourselves and what other financial options are available. We will keep doing everything we can to make treatment possible for Muk. We share updates on concrete developments on this website and Instagram.
What is FAYUVI and what can treatment do?
FAYUVI, formerly UX111, is a one-time gene therapy given by infusion to children with Sanfilippo type A. It helps cells make the enzyme missing in this disease. Research in children treated early showed that important skills were maintained and continued to develop. Doctors assess whether treatment is suitable for Muk.
FAYUVI (UX111)Will you help Muk take another step forward?
Another donation, large or small, helps. If you cannot donate, you can share Muk’s story. The more people we reach, the better our chance of making this possible together.
Price and progress information: Muk’s family, 19 October 2026. Converted using the ECB reference rate of 16 October 2026. Official FAYUVI information: FDA · Ultragenyx · ECB